Indoco Remedies Ltd., a fully integrated, research-oriented pharmaceutical company, announced the receipt of final approval from the US FDA for Abbreviated New Drug Application (ANDA) for pregabalin capsules 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg. This is a generic equivalent of the Reference Listed Drug, Lyrica capsules 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg, of Upjohn US 2 LLC.
Strides Pharma`s Generic Pregabalin Receives Approval in the U.S.
Two painkillers Tapentadol and Pregabalin may go off OTC over misuse
Sandoz`s Pregabalin Receives Approval in Europe
Sinotherapeutics' Generic Pregabalin Receives Receives Approval in the U.S.
ScieGen's Generic Pregabalin Receives Approval in the U.S.
The US Food and Drug Administration (FDA) has given final approval to market Zydus’s Venlafaxine Extended-Release Tablets, USP 37.5 mg, 75 mg, 150 mg and 225 mg Venlafaxine Hydrochloride Extended-Release Tablets. The company also received the final approval from FDA to market Pregabalin Extended-Release Tablets, USP 82.5 mg, 165 mg and 330 mg, a statement from Zydus Lifesciences has notified.
Prinston's Generic Pregabalin Receives Approval in the U.S.
Zydus's Generic Pregabalin Receives Approval in the U.S.